Advance Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Advance Capital Management's LLY Position: Q3 2026 in Review
Advance Capital Management increased its Eli Lilly (LLY) stake by 1.7% in Q3 2026, buying an estimated $54.3K and bringing the position to 2,724 shares worth $3.15M. The position accounts for 0.1% of the portfolio, ranked #39.
Advance Capital Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.21M in Q2 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Advance Capital Management held 2,724 shares of Eli Lilly worth $3.15M as of Q3 2026.
- Advance Capital Management bought 46 Eli Lilly shares in Q3 2026, an estimated $54.3K.
- Eli Lilly made up 0.1% of Advance Capital Management's portfolio in Q3 2026, its #39 holding.
- Advance Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- Advance Capital Management's Eli Lilly position peaked at $3.21M in Q2 2026.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Advance Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.